These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36126365)

  • 1. Prevalence, characteristics and outcome of cardiac manifestations in critically-ill antiphospholipid syndrome patients.
    Azoulay LD; Pineton de Chambrun M; Larcher R; Pène F; Argaud L; Mayaux J; Jamme M; Coudroy R; Mathian A; Gibelin A; Azoulay E; Tandjaoui-Lambiotte Y; Dargent A; Beloncle F; Raphalen JH; Troger A; de Prost N; Devaquet J; Contou D; Gaugain S; Trouiller P; Grangé S; Ledochowski S; Lemarie J; Faguer S; Degos V; Moyon Q; Luyt CE; Kerneis M; Combes A; Amoura Z
    J Autoimmun; 2022 Dec; 133():102908. PubMed ID: 36126365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAPS criteria fail to identify most severely-ill thrombotic antiphospholipid syndrome patients requiring intensive care unit admission.
    Pineton de Chambrun M; Larcher R; Pène F; Argaud L; Demoule A; Jamme M; Coudroy R; Mathian A; Gibelin A; Azoulay E; Tandjaoui-Lambiotte Y; Dargent A; Beloncle FM; Raphalen JH; Couteau-Chardon A; de Prost N; Devaquet J; Contou D; Gaugain S; Trouiller P; Grangé S; Ledochowski S; Lemarie J; Faguer S; Degos V; Combes A; Luyt CE; Amoura Z;
    J Autoimmun; 2019 Sep; 103():102292. PubMed ID: 31253464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematological features and alternate diagnoses in critically ill thrombotic antiphospholipid syndrome patients.
    Azoulay LD; Frapard T; Larcher R; Pène F; Argaud L; Mayaux J; Jamme M; Coudroy R; Mathian A; Gibelin A; Azoulay E; Tandjaoui-Lambiotte Y; Dargent A; Beloncle FM; Raphalen JH; Bréchot N; de Prost N; Devaquet J; Contou D; Gaugain S; Trouiller P; Grangé S; Ledochowski S; Lemarie J; Faguer S; Degos V; Frere C; Quentric P; Moyon Q; Luyt CE; Combes A; Amoura Z; Pineton de Chambrun M
    Clin Rheumatol; 2024 Sep; 43(9):2889-2898. PubMed ID: 39073513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-Hospital Mortality-Associated Factors in Patients With Thrombotic Antiphospholipid Syndrome Requiring ICU Admission.
    Pineton de Chambrun M; Larcher R; Pène F; Argaud L; Mayaux J; Jamme M; Coudroy R; Mathian A; Gibelin A; Azoulay E; Tandjaoui-Lambiotte Y; Dargent A; Beloncle FM; Raphalen JH; Couteau-Chardon A; de Prost N; Devaquet J; Contou D; Gaugain S; Trouiller P; Grangé S; Ledochowski S; Lemarie J; Faguer S; Degos V; Luyt CE; Combes A; Amoura Z
    Chest; 2020 May; 157(5):1158-1166. PubMed ID: 31783015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-criteria manifestations in primary antiphospholipid syndrome: a French multicenter retrospective cohort study.
    Guédon AF; Catano J; Ricard L; Laurent C; de Moreuil C; Urbanski G; Deriaz S; Gerotziafas G; Elalamy I; Audemard A; Chasset F; Alamowitch S; Sellam J; Maillot F; Boffa JJ; Cohen A; Abisror N; Fain O; Mekinian A
    Arthritis Res Ther; 2022 Jan; 24(1):33. PubMed ID: 35078523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form.
    Kolitz T; Shiber S; Sharabi I; Winder A; Zandman-Goddard G
    Front Immunol; 2019; 10():941. PubMed ID: 31134062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress perfusion Cardiac Magnetic Resonance in Patients with Antiphospholipid Syndrome.
    Tektonidou MG; Sfikakis PP; Kolovou G; Mavrogeni S
    Mediterr J Rheumatol; 2018 Jun; 29(2):99-102. PubMed ID: 32185309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined brain/heart magnetic resonance imaging in antiphospholipid syndrome-two sides of the same coin.
    Markousis-Mavrogenis G; Sfikakis PP; Mavrogeni SI; Tektonidou MG
    Clin Rheumatol; 2021 Jul; 40(7):2559-2568. PubMed ID: 33196982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac manifestations other than valvulopathy in antiphospholipid syndrome: long-time echocardiography follow-up study.
    Pardos-Gea J; Avegliano G; Evangelista A; Vilardell M; Ordi-Ros J
    Int J Rheum Dis; 2015 Jan; 18(1):76-83. PubMed ID: 24131635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of inherited thrombophilia and antiphospholipid syndrome in myocardial infarction with non-obstructive coronary arteries: Comparison with cryptogenic stroke.
    Stepien K; Nowak K; Wypasek E; Zalewski J; Undas A
    Int J Cardiol; 2019 Sep; 290():1-6. PubMed ID: 31133433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of critically ill patients with septic shock and sepsis-associated cardiomyopathy using cardiovascular MRI.
    Muehlberg F; Blaszczyk E; Will K; Wilczek S; Brederlau J; Schulz-Menger J
    ESC Heart Fail; 2022 Aug; 9(4):2147-2156. PubMed ID: 35587684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of patients with and without cardiac magnetic resonance imaging abnormalities presenting with myocardial infarction with non-obstructive coronary arteries (MINOCA).
    Tayal B; Freeman P; Ericsson F; Kragholm KH; Andersen NH; Hagendorff A; Aaroe J; Sogaard P; Zaremba T
    Acta Cardiol; 2021 Sep; 76(7):760-768. PubMed ID: 32594904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac involvement in antiphospholipid syndrome: The diagnostic role of noninvasive cardiac imaging.
    Mavrogeni SI; Sfikakis PP; Kitas GD; Kolovou G; Tektonidou MG
    Semin Arthritis Rheum; 2016 Apr; 45(5):611-6. PubMed ID: 26616201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morbidity and mortality in the antiphospholipid syndrome.
    Espinosa G; Cervera R
    Curr Opin Pulm Med; 2009 Sep; 15(5):413-7. PubMed ID: 19436204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvascular obstruction extent predicts major adverse cardiovascular events in patients with acute myocardial infarction and preserved ejection fraction.
    Galea N; Dacquino GM; Ammendola RM; Coco S; Agati L; De Luca L; Carbone I; Fedele F; Catalano C; Francone M
    Eur Radiol; 2019 May; 29(5):2369-2377. PubMed ID: 30552479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of echocardiographic and cardiac magnetic resonance imaging abnormalities during follow-up in patients with multisystem inflammatory syndrome in children.
    Sirico D; Basso A; Sabatino J; Reffo E; Cavaliere A; Biffanti R; Cerutti A; Castaldi B; Zulian F; Da Dalt L; Di Salvo G
    Eur Heart J Cardiovasc Imaging; 2022 Jul; 23(8):1066-1074. PubMed ID: 35639926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymptomatic myocardial ischemic disease in antiphospholipid syndrome: a controlled cardiac magnetic resonance imaging study.
    Sacré K; Brihaye B; Hyafil F; Serfaty JM; Escoubet B; Zennaro MC; Lidove O; Laissy JP; Papo T
    Arthritis Rheum; 2010 Jul; 62(7):2093-100. PubMed ID: 20506512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome.
    Djokovic A; Stojanovich L; Kontic M; Stanisavljevic N; Radovanovic S; Marisavljevic D
    Isr Med Assoc J; 2014 Mar; 16(3):162-7. PubMed ID: 24761704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac involvement in the catastrophic antiphospholipid syndrome (CAPS): Lessons from the "CAPS registry".
    Pons I; Jeréz A; Espinosa G; Rodríguez-Pintó I; Erkan D; Shoenfeld Y; Cervera R;
    Semin Arthritis Rheum; 2024 Jun; 66():152439. PubMed ID: 38552300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.